A Phase II Trial of Abiraterone With Dutasteride for Second‐Generation Antiandrogen‐ and Chemotherapy‐Naïve Patients With Castration‐Resistant Prostate Cancer-Reference-Cited by-同舟云学术

A Phase II Trial of Abiraterone With Dutasteride for Second‐Generation Antiandrogen‐ and Chemotherapy‐Naïve Patients With Castration‐Resistant Prostate Cancer

Published:2023-01-17 Issue:4 Volume:63 Page:445-454
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Shiota Masaki¹^ORCID,Inoue Ryo²,Tashiro Kojiro³,Kobayashi Keita²,Horiyama Shizuyo⁴,Kanji Hiromi⁴,Eto Masatoshi¹,Egawa Shin³,Haginaka Jun⁵^ORCID,Matsuyama Hideyasu²^ORCID

Affiliation:

1. Department of Urology, Graduate School of Medical Sciences Kyushu University Fukuoka Japan

2. Department of Urology, Graduate School of Medicine Yamaguchi University Ube Japan

3. Department of Urology The Jikei University School of Medicine Tokyo Japan

4. School of Pharmacy and Pharmaceutical Sciences Mukogawa Women's University Nishinomiya Japan

5. Institute of Biosciences Mukogawa Women's University Nishinomiya Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2191